The utility of pharmacogenetics testing in psychiatric populations

Publikation: Bidrag til tidsskriftLederForskningfagfællebedømt

Standard

The utility of pharmacogenetics testing in psychiatric populations. / Jürgens, Gesche.

I: Journal of Personalized Medicine, Bind 11, Nr. 12, 1262, 2021.

Publikation: Bidrag til tidsskriftLederForskningfagfællebedømt

Harvard

Jürgens, G 2021, 'The utility of pharmacogenetics testing in psychiatric populations', Journal of Personalized Medicine, bind 11, nr. 12, 1262. https://doi.org/10.3390/jpm11121262

APA

Jürgens, G. (2021). The utility of pharmacogenetics testing in psychiatric populations. Journal of Personalized Medicine, 11(12), [1262]. https://doi.org/10.3390/jpm11121262

Vancouver

Jürgens G. The utility of pharmacogenetics testing in psychiatric populations. Journal of Personalized Medicine. 2021;11(12). 1262. https://doi.org/10.3390/jpm11121262

Author

Jürgens, Gesche. / The utility of pharmacogenetics testing in psychiatric populations. I: Journal of Personalized Medicine. 2021 ; Bind 11, Nr. 12.

Bibtex

@article{0abc0a20143441abb09227e0224e4b3b,
title = "The utility of pharmacogenetics testing in psychiatric populations",
abstract = "The implementation of pharmacogenetic tests including multiple gene variants has shown promising potential as a decision-making tool for optimizing psychopharmacological treatment regimens and reducing treatment costs. However, the varying clinical validity of gene variants included in pharmacogenetic test batteries, and inconsistencies in their translation into medical recommendations between commercially available pharmacogenetic tests, complicates their rational implementation. Thus, there is a need for well-designed, reproducible studies documenting the clinical significance of the various genetic variants.",
keywords = "Pharmacogenetic testing, Pharmacotherapy, Psychiatric disorders",
author = "Gesche J{\"u}rgens",
note = "Publisher Copyright: {\textcopyright} 2021 by the author. Licensee MDPI, Basel, Switzerland.",
year = "2021",
doi = "10.3390/jpm11121262",
language = "English",
volume = "11",
journal = "Journal of Personalized Medicine",
issn = "2075-4426",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

RIS

TY - JOUR

T1 - The utility of pharmacogenetics testing in psychiatric populations

AU - Jürgens, Gesche

N1 - Publisher Copyright: © 2021 by the author. Licensee MDPI, Basel, Switzerland.

PY - 2021

Y1 - 2021

N2 - The implementation of pharmacogenetic tests including multiple gene variants has shown promising potential as a decision-making tool for optimizing psychopharmacological treatment regimens and reducing treatment costs. However, the varying clinical validity of gene variants included in pharmacogenetic test batteries, and inconsistencies in their translation into medical recommendations between commercially available pharmacogenetic tests, complicates their rational implementation. Thus, there is a need for well-designed, reproducible studies documenting the clinical significance of the various genetic variants.

AB - The implementation of pharmacogenetic tests including multiple gene variants has shown promising potential as a decision-making tool for optimizing psychopharmacological treatment regimens and reducing treatment costs. However, the varying clinical validity of gene variants included in pharmacogenetic test batteries, and inconsistencies in their translation into medical recommendations between commercially available pharmacogenetic tests, complicates their rational implementation. Thus, there is a need for well-designed, reproducible studies documenting the clinical significance of the various genetic variants.

KW - Pharmacogenetic testing

KW - Pharmacotherapy

KW - Psychiatric disorders

U2 - 10.3390/jpm11121262

DO - 10.3390/jpm11121262

M3 - Editorial

C2 - 34945734

AN - SCOPUS:85120805596

VL - 11

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

SN - 2075-4426

IS - 12

M1 - 1262

ER -

ID: 305555592